Dosimetric treatment planning in nuclear medicine therapies

Introduction Dosimetric studies are presented for the 90Y Radiopeptide therapy and the 131I thyroid treatments. Purpose In the 131I thyroid treatments, the PreTherapeutic dosimetry has the purpose of identifying the optimal activity to be administered to the target in a single solution and in the metastases to evaluate the dose to red marrow. In the Radiopeptide therapy timed in 6–8 cycles, after the first and last cycle PostTherapeutic...